Central nervous system involvement by epithelial ovarian carcinoma is rare. We report the case of a 49 year old woman with stage IV serous carcinoma of the ovary who developed multiple cerebral and cerebellar metastases 7 months after achieving complete response to platin-based chemotherapy. Eight courses of carboplatin (400 mg/m 2 ) were administered and after the second cycle complete remission of the brain deposits occured. The treatment afforded rapid subjective and objective relief and was associated with a good quality of life. Abdominal recurrent disease was diagnosed 22 months after treatment for brain involvement. Paltin-based chemotherapy was reinstated, but the patient died from progressive adbominal disease without any sign of cerebral involvement and any neurological symptomatology. Carboplatin should be considered for the treatment of ovarian carcinoma metastatic to the brain

Cormio, G., Gabriele, A., Maneo, A., Zanetta, G., Bonazzi, C., Landoni, F. (1998). Complete remission of brain metastases from ovarian carcinoma with carboplatin. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 78(1), 91-93 [10.1016/S0301-2115(98)00009-8].

Complete remission of brain metastases from ovarian carcinoma with carboplatin

Landoni F.
1998

Abstract

Central nervous system involvement by epithelial ovarian carcinoma is rare. We report the case of a 49 year old woman with stage IV serous carcinoma of the ovary who developed multiple cerebral and cerebellar metastases 7 months after achieving complete response to platin-based chemotherapy. Eight courses of carboplatin (400 mg/m 2 ) were administered and after the second cycle complete remission of the brain deposits occured. The treatment afforded rapid subjective and objective relief and was associated with a good quality of life. Abdominal recurrent disease was diagnosed 22 months after treatment for brain involvement. Paltin-based chemotherapy was reinstated, but the patient died from progressive adbominal disease without any sign of cerebral involvement and any neurological symptomatology. Carboplatin should be considered for the treatment of ovarian carcinoma metastatic to the brain
Articolo in rivista - Articolo scientifico
Brain metastasis; Carboplatin; Ovarian carcinoma; Antineoplastic Agents; Brain Neoplasms; CA-125 Antigen; Carboplatin; Cystadenoma, Serous; Fatal Outcome; Female; Humans; Middle Aged; Ovarian Neoplasms; Remission Induction
English
1998
78
1
91
93
none
Cormio, G., Gabriele, A., Maneo, A., Zanetta, G., Bonazzi, C., Landoni, F. (1998). Complete remission of brain metastases from ovarian carcinoma with carboplatin. EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY, 78(1), 91-93 [10.1016/S0301-2115(98)00009-8].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/264926
Citazioni
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 25
Social impact